ALDX INVESTOR ALERT: An Investigation was Initiated on behalf of Aldeyra Therapeutics, Inc. Shareholders - Contact BFA Law

  • NEW YORK CITY, NY / ACCESS Newswire / April 18, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) for potential violations of the federal securities laws. If you invested in Aldeyra Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/aldeyra-therapeutics-inc.